Currently, the EXOMA2 study (NCT04614480) offers earlier and more comprehensive exome analysis in the management of cancer patients than EXOMA. Based on the active EXOMA2 patient file, the INFOGene study offers the opportunity to study patient-physician communication, to assess patient preferences with regard to different information modalities concerning theranostic exome analysis, and to reflect on information modalities to ensure optimal patient comprehension of the information provided.
The qualitative cross-sectional study includes a dual observational and interventional component involving cancer patients. The patients will come from the EXOMA 2 active file at Dijon University Hospital and the CGFL.
Patient identified for inclusion in the EXOMA 2 study (exome analysis request)
Available to receive different types of information
Fluent in French
No prior oncogenetic consultation
Patient who refused to participate in the EXOMA2 study (for phase 3 patients only)
Has a psychiatric, cognitive or neurological disorder that makes participation impossible
Working in the field of genetics